These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The International Academy of Compounding Pharmacists Introduces a New President. Rice B Int J Pharm Compd; 2017; 21(2):116-117. PubMed ID: 28346206 [No Abstract] [Full Text] [Related]
4. Mexico's drug policy reform: cutting edge success or crisis in the making? Werb D; Mora ME; Beletsky L; Rafful C; Mackey T; Arredondo J; Strathdee SA Int J Drug Policy; 2014 Sep; 25(5):823-5. PubMed ID: 24974368 [No Abstract] [Full Text] [Related]
5. Subpoena for Scully sought. Tieman J Mod Healthc; 2004 Apr; 34(14):8-9. PubMed ID: 15095493 [No Abstract] [Full Text] [Related]
6. Not satisfied. Democrats call for independent probe of Scully. Taylor M Mod Healthc; 2004 Jul; 34(28):12. PubMed ID: 15270389 [No Abstract] [Full Text] [Related]
7. Inquiry says that "UK drugs policy is failing". Burki T Lancet; 2019 Nov; 394(10209):1605. PubMed ID: 31690436 [No Abstract] [Full Text] [Related]
8. Big data's big bias: bringing noise and conflicts to US drug regulation. Lenzer J BMJ; 2017 Jul; 358():j3275. PubMed ID: 28720567 [No Abstract] [Full Text] [Related]
10. US drug strategy runs counter to Canada's. Webster PC CMAJ; 2013 Aug; 185(11):E513-4. PubMed ID: 23754111 [No Abstract] [Full Text] [Related]
11. Caveat emptor: regulating the online medicine man in the new frontier. Stolfi P J Contemp Health Law Policy; 2000; 17(1):377-401. PubMed ID: 11216344 [No Abstract] [Full Text] [Related]
12. Reflections of a forensic psychiatrist in Washington: politics and policy. Binder RL J Am Acad Psychiatry Law; 2004; 32(3):324-8. PubMed ID: 15515924 [No Abstract] [Full Text] [Related]
13. Old lessons relearnt. Loder E BMJ; 2016 Nov; 355():i6153. PubMed ID: 27856442 [No Abstract] [Full Text] [Related]
14. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients. Monaghan M; Wincup E Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401 [TBL] [Abstract][Full Text] [Related]
15. Federal law and syringe prescription and dispensing. Abrahamson D Health Matrix Clevel; 2001; 11(1):65-71. PubMed ID: 11345677 [No Abstract] [Full Text] [Related]
16. Health care reform and pharmaceutical care. Rodriguez LR Am J Hosp Pharm; 1994 Jun; 51(11):1467-8. PubMed ID: 7942880 [No Abstract] [Full Text] [Related]
17. Regulation of compounding by the food and drug administration: a tale of 2 circuits. Williams KG J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854 [TBL] [Abstract][Full Text] [Related]
18. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament. Bottomley A; Kirby T; Bean J; Walker J Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444 [TBL] [Abstract][Full Text] [Related]
19. Orszag exit looms...as speculation grows over effect on health reform. Lubell J Mod Healthc; 2010 Jun; 40(26):10. PubMed ID: 20635504 [No Abstract] [Full Text] [Related]
20. Drug policy reform: societal and clinical perspectives. Newman RG Bull N Y Acad Med; 1995; 72(2):321-34. PubMed ID: 10101372 [No Abstract] [Full Text] [Related] [Next] [New Search]